Overproduction of Bacillus amyloliquefaciens extracellular glutamyl-endopeptidase as a result of ectopic multi-copy insertion of an efficiently-expressed mpr gene into the Bacillus subtilis chromosome by Yomantas, Yurgis AV et al.
RESEARCH Open Access
Overproduction of Bacillus amyloliquefaciens
extracellular glutamyl-endopeptidase as a result
of ectopic multi-copy insertion of an efficiently-
expressed mpr gene into the Bacillus subtilis
chromosome
Yurgis AV Yomantas, Elena G Abalakina, Lyubov I Golubeva, Lyubov Y Gorbacheva and Sergey V Mashko
*
Abstract
Background: Plasmid-less, engineered Bacillus strains have several advantages over plasmid-carrier variants.
Specifically, their stability and potential ecological safety make them of use in industrial applications. As a rule,
however, it is necessary to incorporate many copies of a key gene into a chromosome to achieve strain
performance that is comparable to that of cells carrying multiple copies of a recombinant plasmid.
Results: A plasmid-less B. subtilis JE852-based strain secreting glutamyl-specific protease (GSP-the protein product
of the mpr gene from B. amyloliquefaciens) was constructed that exhibits decreased levels of other extracellular
proteases. Ten copies of an mpr
B.amy cassette in which the GSP gene was placed between the promoter of the B.
amyloliquefaciens rplU-rpmA genes and the Rho-independent transcription terminator were ectopically inserted into
designated (3 copies) and random (7 copies) points in the recipient chromosome. The resulting strain produced
approximately 0.5 g/L of secreted GSP after bacterial cultivation in flasks with starch-containing media, and its
performance was comparable to an analogous strain in which the mpr
B.amy cassette was carried on a multi-copy
plasmid.
Conclusion: A novel strategy for ectopically integrating a cassette into multiple random locations in the B. subtilis
chromosome was developed. This new method is based on the construction of DNA fragments in which the
desired gene, marked by antibiotic resistance, is sandwiched between “front” and “back” portions of random
chromosomal DNA restriction fragments. These fragments were subsequently inserted into the targeted sites of the
chromosome using double-cross recombination. The construction of a marker-free strain was achieved by gene
conversion between the integrated marked gene and a marker-less variant carried by plasmid DNA, which was
later removed from the cells.
Background
Gram-positive bacteria are widely used for biotechnol-
ogy applications, including vaccine delivery [1-3] and in
situ production of anti-infective protectants [4] and
microbicides [5]. These microorganisms serve as large-
scale producers of nucleotides, vitamins, ribose, poly-g-
glutamic acids [6], absorbents [7], and insecticides [8].
Bacillus species are considered prospective cell-based
factories for pharmaceutical proteins [9]. Currently,
about 60% of commercially-available industrial enzymes
are produced by selected and/or genetically-engineered
Bacillus strains, most of which produce homologous
proteins that are naturally secreted into the growth
medium [6,9-15].
Bacillus subtilis produces numerous extracellular pro-
teolytic enzymes. The alkaline serine protease subtilisin
and the neutral protease (gene products of aprE and
nprE, respectively) often constitute more than 90% of
the total extracellular protease activity [9,16]. The
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does not normally exceed 2% [17]. B. subtilis GSP,
encoded by the mpr gene, is synthesized as an inactive
pre-pro-peptide. This precursor is subsequently pro-
cessed by the Sip and Bpr proteases, and mature extra-
cellular GSP have a length of 220 amino acids [17].
Though they were initially a subject of basic science
investigation [18-20], some GSPs (from B. licheniformis
in particular [21]) are now being utilized in commercial
applications such as food production [22,23].
A traditional approach to the genetic engineering of
Bacillus strains involves the introduction of multi-copy-
number recombinant plasmids [10]. However, the con-
struction of plasmid-less strains has recently become
more relevant and practical. The preference for plasmid-
less Bacillus strains is due to the genetic instability of
many recombinant plasmids [24,25] and to official
restrictions that concern the use of plasmid-carrying
strains in large-scale industry in the First World [26].
Most often, the construction of plasmid-less Bacillus
strains is performed by homologous recombination-
mediated integration of the desired genes into the bac-
terial chromosome [10]. In some instances, specialized
site-specific recombination [27] and transposition
[28,29] are used for the same integrative purposes.
Recombination-mediated DNA incorporation can be
implemented through either Campbell-type single-cross-
over integration of plasmids based on specialized vectors
carrying DNA sequences homologous to the Bacillus
chromosome or through the use of ectopic insertion, i.e.
double-cross recombination between the target in the
chromosome and the homologous flanking sequences
sandwiching the fragment of interest [10,30,31]. Both
methods can be used for single-copy and multi-copy
integrations [32-34]. Single-copy, plasmid-mediated inte-
grants with inserted sequences bracketed by duplicated
homologous regions are not stable under non-selective
conditions due to the possible recombination-mediated
elimination of the inserted plasmid [35]. Ectopic inser-
tion(s) of a desired gene usually leads to significantly
more stable recombinant strains. However, only a nar-
row set of well-characterized loci within the B. subtilis
chromosome is normally used as targets for such inser-
tions [10,36,37].
In this study, a recombinant, plasmid-less B. subtilis
strain was developed that can efficiently produce and
secrete GSP from B. amyloliquefaciens.I n i t i a l l y ,t h r e e
copies of the mpr gene were ectopically inserted into
known B. subtilis genes encoding extracellular proteases.
A novel, random integration methodology was then
implemented to construct a stable strain with 10 mpr
copies within the chromosome. Performance of the new
strain was comparable to the strain carrying the mpr
gene on a multi-copy plasmid, as exhibited by accumu-
lation of the recombinant GSP in the media.
Results
Cloning and expression of B. amyloliquefaciens mpr on a
B. subtilis plasmid
T h en u c l e o t i d es e q u e n c eo ft h empr gene from B. amy-
loliquefaciens A-50 was not known. Primers for the
amplification of mpr by PCR, mpr-F/R (the structures of
the primers used in this study were presented in Addi-
tional file 1, Table S1), were therefore designed based
on the available B. amyloliquefaciens ZB42 genome
sequence (GenBank/EMBL accession number
NC_009725) [38]. DNA amplicons of 972 base pairs
(bp) in length were obtained and sequenced (GenBank
accession number GU992366). The corresponding DNA
sequence closely coincided with the mpr-containing
sequence from B. amyloliquefaciens FZB42 (91% of
identity) and covered the 909-bp open reading frame.
An extended AG-rich block, including a B. subtilis
Shine-Dalgarno sequence, AAGGAGG [39], was found
upstream of the ATG codon of this ORF. The protein-
coding ORF possessed 68% identity to well-characterized
pre-pro-GSP from B. subtilis [17,18,20].
The mpr-carrier amplicon, flanked by artificial BglII
sites (P1-bmp5 and P2-bmp2 were used as the primers),
was cloned into the BglII site of the pHEA323 plasmid
[40]. This placed it under the transcriptional control of
the promoter (Prp)o ft h erplU-rpmA genes from B.
amyloliquefaciens A-50, which encode the L21 and L27
ribosomal proteins. In the resulting pHE52mpr recombi-
nant plasmid, the cloned mpr gene became the central
part of an artificial operon that was terminated by the
Rho-independent transcription terminator (Ter) from
the pheA gene of B. amyloliquefaciens A-50 (Figure 1).
As was shown previously [40] and confirmed in the pre-
sent study, the presence of Ter for the termination of
efficient Prp-mediated transcription is conducive to the
stable inheritance of pHEA323 and its derivatives (i.e.,
mpr
B.amy cassettes (Prp➔mpr-Ter) in the pHE52mpr plas-
mid and/or integrated into the bacterial chromosome).
Mpr gene expression studies were performed with the
B. subtilis strain JE852 serving as a recipient. This strain
was a double mutant for genes encoding two major
extracellular proteases (nprE512, aprE851), which sim-
plified the assessment of recombinant GSP activity.
Initially, a plasmid-carrying, recombinant GSP-produ-
cing strain was constructed via the transformation of B.
subtilis JE852 with pHE52mpr. The level of GSP accu-
mulation was analyzed by the semi-quantitative skim
milk method on media containing different carbon
sources and by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) analysis of extracellular
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expression of the mpr
B.amy cassette was under carbon
catabolite control (CCC) in B. subtilis.I n d e e d ,w h e n
glucose or maltose were added to the media, B. subtilis
JE852/pHE52mpr g r e ww e l lb u td i dn o tf o r mc l e a r ,
hydrolytic zones around colonies on milk agar. On the
other hand, during growth on medium containing solu-
ble starch as the sole carbon source, abundant amounts
of GSP accumulated and were easily distinguished from
the other extracellular proteins by SDS-PAGE. The
main mechanism of CCC in Bacillus has been well stu-
died [41-44]. CCC is implemented through the binding
of the CcpA-mediated regulatory protein complex to
special DNA sites known as catabolite responsive ele-
ments (cre). This binding causes carbon catabolite
repression (CCR) or activation (CCA), depending on the
position of the cre. For example, when the regulatory
complex binds to cre that is located downstream of the
transcription initiation point, it evokes a transcription
roadblock that leads to CCR of the corresponding genes
[44]. Two putative catabolite responsive elements that
were homologous to consensus cre sequences [44-46]
were found in the N-terminal coding part of the B. amy-
loliquefaciens A-50 mpr gene by sequence analysis (Fig-
ure 1). It is possible that the CCR of mpr gene
expression that we observed was caused by termination
of transcription at these cre sites when they were bound
to the CcpA-mediated regulatory complex. Moreover,
the data suggest that a complicated regulatory network
governs Bacillus extracellular proteolytic activity with
CCR and that there may be changes in the control of
enzyme biosynthesis, secretion, and/or maturation at
different stages of bacterial growth [41,42,47].
Defining the mechanism of CCR modulation of GSP
extracellular accumulation was outside the scope of the
present paper. We showed that GSP production was sig-
nificantly increased during fermentation of the B. subti-
lis JE852/pHE52mpr strain on TYS6C media, in which
starch was the main carbon source. In this media, an
enhanced biomass (growing up to an OD600 of around
40-50) and high level of extracellular GSP accumulation
(up to approximately 0.5 g/L, as semi-quantitatively
determined by SDS-PAGE, see Materials and methods)
were detected. These results were obtained for the strain
carrying multi-copy-number recombinant plasmids, sug-
gesting that the integration of multiple copies of the
mpr
B.amy-cassettes into the bacterial chromosome is
indispensable for achieving comparably high GSP pro-
duction levels in a plasmid-less Bacillus strain.
Ectopic insertion of mpr
B.amy cassettes into genes
encoding known extracellular proteases
Ectopic insertion of several mpr
B.amy cassettes was per-
formed to simultaneously inactivate known extracellular
protease genes of B. subtilis: aprE, epr and nprB.T h e
overall scheme of mpr
B.amy cassette insertion had three
stages (see Figure 2 where the mpr
B.amy cassette inser-
tion into the aprE851 allele of B. subtilis JE852 strain is
shown as an example). First, a linear DNA fragment
consisting of an antibiotic resistance (AntR) marker
flanked with homologous arms was integrated into the
corresponding chromosomal region via double-crossover
recombination. Then, the AntR marker was exchanged
for the mpr
B.amy cassette by gene conversion (for a
review, see [48,49]) between the chromosome and the
Figure 1 Structure of the pHE52mpr plasmid carrying the mpr
B.
amy cassette.P rp - promoter of the rplU-rpmA genes from B.
amyloliquefaciens A-50; Ter - Rho-independent transcription
terminator of the pheA gene. The BglII-site-ended (boldface)
followed by 5’-portion of B. amyloliquefaciens A-50 mpr gene is
shown. In this part, SD-sequence and ATG-codon are marked as
boldface and capital letters, respectively. Two putative cre elements,
which are homologous to the known [45-47] consensus sequence,
are also indicated.
Figure 2 Scheme of the targeted mpr
B.amy-cassette integration
into the JE852 chromosome (aprE851 is shown as an example
of the target gene).
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B.amy-carrying plasmid,
and this was followed by plasmid curing and construc-
tion of the plasmid-less, targeted integrant.
The aprE851 gene in B. subtilis JE852 was chosen as
the first target gene for mpr
B.amy cassette insertion, pri-
marily to prevent reversion of the mutant allele to the
wild-type phenotype during the proposed long-term
construction of a GSP-producing, plasmid-less strain.
The Cm
R gene from pC194 [50] was used as the AntR
marker for selective integration at the first stage. The
linear fragment, used for aprE851 gene disruption, was
constructed in vitro by overlapping PCR technique (see
Materials and methods and Additional file 2, Figure
S1 for details). The targeted integration of the Cm
R
marker was followed by gene conversion using the Em
R-
marked recombinant plasmid pCBT(yhfO-mpr
B.amy-
yhfN) and subsequent selection of the obtained Em
R
Cm
S clones, which were generated at a frequency of
around 2%. Finally, the plasmid-less (Em
S) variants were
selected after bacterial cultivation in liquid erythromy-
cin-free medium. All integration stages were assessed by
PCR, and the chromosome structure of the B. subtilis
JE852aprE851::mpr
B.amy strain was analyzed by PCR and
using Southern hybridization.
The same method, with modifications based on the
nucleotide sequences of the target genes, was used for
step-by-step ectopic insertion of the mpr
B.amy cassette
into the epr and nprB genes, encoding two minor extra-
cellular proteases of B. subtilis (see Materials and
methods and Additional file 1, Table S1 for details).
This process resulted in the desired B. subtilis strain, a
JE852-based plasmid-less, marker-less strain, JE852
(aprE851, epr, nprB)::mpr
B.amy, with three integrated
mpr
B.amy cassettes.
The dependence of GSP accumulation on the inte-
grated cassette copy-number (N) was evaluated accord-
ing to the semi-quantitative plate test based on casein
hydrolysis (Figure 3) and using SDS-PAGE analysis of
extracellular bacterial proteins (Figure 4). The results
showed that GSP production was significantly lower
than that of a recombinant strain that had multiple plas-
mid copies, even for the plasmid-less strain, which had
three cassette insertions (N = 3). This finding suggested
that the process of cassette amplification needed to be
continued. However, simplifying the procedure to obtain
many single-copy integrants and then combining the
variants possessing segregation stability became an
attractive option.
Integration of the mpr
B.amy cassette into random sites in
the bacterial genome
A key aspect of the novel strategy presented here is the
construction of DNA fragments in which the AntR-
marked cassette (mpr
B.amy-AntR) is sandwiched between
the “front” and “back” portions of randomly digested
fragments of the recipient chromosome. The proposed
scheme is presented in Figure 5. Initially, pHE52(mpr-
Cm
R) was constructed (see Materials and methods).
This plasmid carried the mpr
B.amy-Cm
R cassette that
was bracketed by PstI-sites and did not contain internal
BamHI-sites. The PstI-generated mpr
B.amy-Cm
R cassette
is marked as (a) in Figure 5. The BamHI-generated
DNA fragments of the B. subtilis JE852 chromosome
((b) fragments in Figure 5) were self-circularized by T4
ligase at a low DNA concentration and subsequently
cleaved by PstI. (b)-fragments in Figure 5 were a mix-
ture of PstI-site(s)-carrying (b1)a n dPstI-site-free (b2)
fragments. The (b1)-fragment with two internal PstI-
sites was shown in the Figure 5 for simplicity. The self-
circularized (b2) fragments could not be linearized by
PstI and so would not be later linked with the (a)-frag-
ment. In contrast, the self-circularized (b1)-fragments
hydrolyzed by PstI generated a mixture of BamHI-site-
carrier (c1)a n dBamHI-site-free (c2) linear DNA frag-
ments. The ligation of (c1)-fragments with (a)-fragment
followed by BamHI treatment caused formation of lin-
ear (Lin) fragments consisting of the cassette of interest
sandwiched by “front” and “back” homologous arms.
These (Lin)-fragments could participate in subsequent
double-cross recombination-mediated integration into
the bacterial chromosome. (c2)-fragments could be
Figure 3 Cells plated on skim-milk test plates: The dependence
of extracellular protease activity on the copy number of the
integrated mpr
B.amy cassettes. 1.-clone of B. subtilis JE852; 2. and
3.-1 and 3 copies of mpr
B.amy-cassette integrated in the
chromosome of JE852; 4.-clone of the plasmid-carrier strain B.
subtilis JE852/pHE52mpr.
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recombinant DNAs, (Cir)-fragments, were resistant to
BamHI-mediated cleavage and could be integrated into
t h ec h r o m o s o m eo n l yv i aas i n gle-cross Campbell-type
recombination. It could be supposed that the number of
(Cir)-mediated integrants would be more than (Lin)-
mediated ectopic insertions [10]. At the same time, the
(Cir)-mediated integrant with the cassette sandwiched
between directly repeated (c2)-fragments (see Figure 5)
could be rather unstable due to the possibility of recom-
bination-dependent elimination of the cassette.
The success of the strategy led to the formation of
about 250 Cm
R clones after transformation of the B.
subtilis JE852 strain. These colonies were tested for
their ability to grow on minimal media with glucose as
the sole carbon source. Prototrophic Cm
R strains (190
colonies) were then tested for their segregation stability
(see Materials and methods for details). Fifteen trans-
formants that demonstrated 100% segregation stability
after 60 generations were used in the experiments that
followed. According to data from the literature [10], it
could be supposed that the stable integrants were
obtained due to the intrinsic ectopic insertions, whereas
transformants that manifested decreased segregation sta-
bility were the result of Campbell-type integration.
According to experimental evaluation (including
growth on skim milk plates and SDS-PAGE analysis of
extracellular proteins), all 15 stable integrants produced
and secreted GSP at slightly variable levels, and the
levels corresponded to the presence of one mpr
B.amy cas-
sette in the chromosome of B. subtilis JE852. Testing by
Southern hybridization confirmed that these strains car-
ried only one mpr
B.amy-Cm
R cassette integrated into dif-
f e r e n tc h r o m o s o m a ll o c i( s e eF i g u r e4w h e r er e s u l t sf o r
the corresponding marker-free mpr
B.amy-cassettes were
presented). The strains from this set were designated,
for example, B. subtilis JE852-(69xyz::mpr
B.amy-Cm
R).
Here the number, 69 (84, 85, 114, etc. for the other
strains), indicates the strain number in the laboratory
collection, while the uniform three-letter appellation for
all strains, xyz, indicates that the location of the cassette
integration was not determined.
Step-by-step increase of the mpr
B.amy cassette
chromosomal copy number
The set of strains with integrated mpr
B.amy-Cm
R cas-
settes was used to increase the occurrence of the mpr
B.
amy gene in the genome of a strain that initially
Figure 4 A Southern hybridization of the chromosomal DNA
isolated from cells carrying different copy-number (N) of the
integrated mpr
B.amy-cassettes (indicated as 1.; 2.; 3; etc. (N = 1:
lane 1 (1.); N = 2: lane 2 (1.+2.); N = 4: lane 3 (1.+2.+3.+4.); and
N = 7: lane 4 (1.+2.+3.+4.+5.+6.+7.) and lane 6 (1.+2.+3.+4.+5.
+6.+8.). B SDS-PAGE of extracellular proteins secreted by the strains
with: N = 0 (lane 2), N = 1 (lane 3), N = 2 (lane 4), N = 3 (lane 5), N
= 9 (lane 8) and N = 10 (lane 9) mpr
B.amy cassettes in the
chromosome or carrying the multi-copy-number recombinant
plasmid pHE52mpr (lanes 6 and 10). Lanes 1 and 7-reference
proteins with molecular mass given in kDa. The mature 220 amino
acid B. amiloliquefaciens GSP has a molecular mass of about 23.7
kDa. The indicated extracellular GSP presented slightly lower
electrophoretic mobility corresponding to 27-28 kDa; this was
previously documented for the mature GSP from B. subtilis [17].
Figure 5 The general scheme of the mpr
B.amy-Cm
R-cassette
integration into random points of the B. subtilis chromosome.
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nprB)::mpr
B.amy. For cassette amplification, extracted
chromosomal DNA from one Cm
R strain was used for
transformation of a marker-less strain carrying N copies
of the mpr
B.amy-cassette (initially N = 3 in these experi-
ments). Selection of Cm
R transformants led to the crea-
tion of a B. subtilis genome that contained N+1 copies
of the gene encoding GSP. At the last step of this round
of cassette amplification, the strain was rendered mar-
ker-less by gene conversion with pHE52mpr followed by
plasmid curing. Then, the next Cm
R-marked cassette
was inserted into the chromosome of the newly
obtained strain, which carried N+1 cassettes.
The level of GSP secretion and the presence of all pre-
viously integrated cassettes in the bacterial genome were
assessed at each stage of the cassette amplification pro-
cess using Southern hybridization and SDS-PAGE analy-
sis of extracellular proteins (Figure 4). As a rule, each
subsequent generation displayed a slightly increased
level of GSP accumulation in comparison to the pre-
vious generation, maintained the earlier integrated cas-
settes at their original positions in the bacterial genome
and presented one novel hybridized DNA fragment that
could be detected in the marker-less derivative of the
corresponding donor strain.
Ultimately, a plasmid-less and marker-less strain car-
r y i n g1 0c o p i e so ft h empr
B.amy cassette was obtained.
This strain efficiently secreted GSP at the same level as
the control, B. subtilis JE852/pHE52mpr.
Conclusion
Efficient production and secretion of B. amyloliquefa-
ciens A-50 GSP by a recombinant plasmid-less B. subti-
lis strain was obtained. The mutant B. subtilis JE852
(nprE, aprE), which possessed significantly decreased
levels of major extracellular proteases, was utilized as
the initial recipient strain. The mpr
B.amy cassette, in
which transcription of the mpr gene was controlled
through a promoter that drives genes for ribosomal pro-
teins in combination with a Rho-independent termina-
tor, was expressed and stably maintained. Finally, the
mpr
B.amy cassette was amplified by multiple ectopic
insertions of the construct into the B. subtilis chromo-
some within known genes initially and then in random
loci according to the methodology described above. The
methods used for these insertions differed slightly but
used the following general steps: (i)a nA n t R - m a r k e d
linear DNA fragment was sandwiched between two
arms that were homologous to a target in the bacterial
genome, (ii) this fragment was incorporated using dou-
ble homologous recombination, (iii)t h em a r k e rw a s
removed by gene conversion between the chromosome
and an introduced plasmid and (iv) the incoming plas-
mid was eliminated from the cell.
It should be mentioned that the efficiency of iterative
gene conversions using the same plasmid, pHE52mpr,
decreased slightly with an increase in the copy number
of the integrated cassettes. This efficiency was about (3
to 4)% when N = 3 or 4 but did not exceed 1% for
strains with N = 9 or 10. Excisable markers that can be
efficiently removed by different site-specific recombina-
tion events [27,51] might be preferable for the amplifica-
tion procedure.
The constructed plasmid-less strain, which has 10
chromosomal mpr
B.amy cassettes, displayed essentially
the same GSP production level as the recombinant plas-
mid-carrying strain. According to data in the literature,
there are likely 20-30 copies of the pSM19035 replicon-
based plasmid in the recombinant plasmid-carrier strain
[10,52,53]. This apparent incongruity has several expla-
nations. First, the copy number of the recombinant
mpr
B.amy-carrier plasmid could be lower than that of the
vector, in particular, because of interference between
plasmid replication and efficient intra-plasmid transcrip-
tion. Second, expression levels of the same gene located
in the chromosome vs. located on a plasmid could differ
due to changes in the DNA curvature; dependence on
restrained superhelical density is typical of protein-
bound DNA molecules [54]. Third, Prp-mediated tran-
s c r i p t i o no fe v e nt e nc o p i e so ft h empr gene may be
inherently efficient, such that the saturated translation/
secretion machinery becomes the true bottleneck for
extracellular GSP accumulation.
Segregation stability is a major factor that must be
considered in the potential practical application of
plasmid-less recombinant strains. As mentioned pre-
viously, only 10% of the clones that had a single-copy
of the mpr
B.amy-carrying cassette integrated at random
points within the bacterial chromosome possessed
strong segregation stability. Amplification of the same
cassettes in one genome could certainly decrease the
strain’s stability due to the potential for homologous
intrachromosomal recombination. Recombination
between directly repeated cassettes can lead to internal
chromosomal deletions such that the strains, posses-
sing essential genes in regions between the cassettes,
have to be protected from these genomic rearrange-
ments. In turn, recombination between inversely
repeated cassettes leading to chromosomal inversions
[55,56] could be the basis of strain instability and, in
particular, the decreased performance of the corre-
sponding strain.
It seems useful to determine the integration points to
finalize the construction of a set of stably-maintained
single-copy cassette integrants. This determination
could be performed using inverse PCR-based methods
[57]. In this case, a task-oriented amplification of the
cassettes could be performed to exclude the formation
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between directly repeated cassettes.
It is possible that this strategy of ectopic multi-copy
integration would be helpful for the construction of a
broad range of plasmid-less, marker-less, recombinant
Bacillus strains for microbial technology applications.
Materials and methods
Bacterial strains, plasmids, and culture conditions
Strains and plasmids used in the present study are
shown in Additional file 3, Table S2.C e l l so fB. amylo-
liquefaciens and B. subtilis were grown at 37°C in liquid
LB media or LB with agar [58] supplemented by antibio-
tics (chloramphenicol (Cm, 5-10 mg/L) or erythromycin
(Em, 10 mg/L) when necessary.
Cells were plated on skim milk (20%) test plates for
semi-quantitative detection of the total extracellular pro-
tease activity; activity was determined by the size of the
clearance zone around each colony [17,22].
The fermentation media TYS6C that was used for
GSP production was composed of the following: 2%
tryptone, 3% yeast extract, 6% soluble starch, 2% corn
steep liquor (CSL), 0.1% CaCl2 (added after autoclaving),
and 1% CaCO3 (added after sterilization) at pH 7.0. A
final concentration of 10 mg/L Em was added to the
media for cultivation of the plasmid-carrying strain. B.
subtilis strains were cultured for 48 hours on a rotary
shaker (at 220 rpm) at 37°C in 750-mL flasks containing
30 mL of media. Seed cultures were standardized by the
preparation of freezer stock (-70°C) cultures in 20% gly-
cerol. Then, 0.15 mL of the seed culture from the gly-
cerol stock was used to inoculate 30 mL of TYS6C
media in a single 750-mL flask. Samples for SDS-PAGE
were taken after 48 hours of bacterial cultivation.
TYS6 media was the same as TYSC media, but with-
out the CSL component. TYS6 media with 2%-4% glu-
cose or maltose was used as the test media for
generating CCR conditions.
Standard genetic engineering methods
Transformation of B. subtilis was performed using the
method described by Spizizen [59].
Treatment of recombinant DNA and Southern hybri-
dization were carried out in accordance with conven-
tional protocols [60]. Chromosomal DNA of B. subtilis
strains was hydrolyzed by EcoRI overnight, separated by
electrophoresis in agarose and hybridized with biotini-
lated, mpr-containing PCR fragments that were ampli-
fied with mprF/mprR primers using pHE52mpr as a
template. The Biotin DecaLabel™ Kit and Biotin Chro-
mogenic Detection Kits (Fermentas, Lithuania) were
used to label and detect DNA.
Preparations of restriction enzymes, T4 DNA ligase
and DNA polymerase I Klenow fragments from
Fermentas were used. Taq DNA polymerase (Fermentas)
or AccuTaqLA DNA polymerase (Sigma, USA) were
used for PCR in accordance with the manufacturers’
instructions. The structures of all primers used in the
present study are listed in Additional file 1, Table S1.
Construction of the pHE52mpr and pHE52(mpr-Cm
R)
plasmids
The pairs of primers mprF/mprR and P1-bmp5/P2-
bmp2 were used for PCR-mediated amplification and
then for cloning of the mpr gene from the chromosomal
DNA of B. amyloliquefaciens A-50. The amplicons, gen-
erated in PCR with P1-bmp5/P2-bmp2 as the primers,
were treated with BglII and inserted into the BglII site
of the pHEA323 plasmid [40] to form the pHE52mpr
plasmid. The Cm
R gene from the pC194 plasmid [50]
was cloned into a BglII-site of the pHE52mpr plasmid
located just downstream of the mpr gene (with coordi-
nate (2,174) in Figure 1). As a result, the pHE52(mpr-
Cm
R) plasmid carrying the mpr
B.amy-Cm
R cassette was
obtained. The mpr
B.amy and mpr
B.amy-Cm
R cassettes had
the mutual DNA fragments not only in proximal part,
but in distal part, as well. The later included B. amyloli-
quefaciens DNA fragment of the pHE52mpr plasmid
(about 1,800 bp in length) consisted of pheA gene and
Ter. So, pHE52mpr plasmid could be efficiently used for
gene conversion resulting in substitution of mpr
B.amy-
Cm
R cassette integrated in the chromosome by the mar-
ker-less mpr
B.amy-cassette from the plasmid (see below).
Construction of the JE852(aprE851, epr, nprB)::mpr
B.amy
strain
The strain JE852(aprE851, epr, nprB)::mpr
B.amy was con-
structed via step-by-step ectopic integration of three
copies of the mpr
B.amy cassette into the aprE851, epr
and nprB genes of the JE852 strain. For each integration,
two target-specific DNA molecules were constructed: (i)
linear Cm
R-carrier DNA fragments for the target gene
inactivation and (ii) mpr
B.amy-carrier plasmids for gene
conversion.
As for integration into the aprE851 gene, the linear
DNA fragment, yhfO’-Cm
R-’yhfN, was constructed in
vitro by overlapping PCR, as shown in Additional file 2,
Figure S1. The final DNA amplicon was treated with
EcoRI and cloned into a pCB20-based [52] plasmid for
the construction of pCBT(yhfO-Cm
R-yhfN). The later
recombinant plasmid was used as a vector for the in
vitro substitution of the Cm
R-marker by the PstI-gener-
ated mpr
B.amy-cassette from pHE52mpr (Figure 1). The
obtained pCBT(yhfO-mpr
B.amy-yhfN) plasmid was used
for in vivo gene conversion, which resulted in construc-
tion of the JE852aprE851::mpr
B.amy strain (Figure 2).
A linear DNA fragment for integration into the epr
gene was designed using Pr7/Pr8 as the primers for
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mosome. Insertion of the PstI-generated amplicon with
the Cm
R gene from pC194 (the primers-Pr9/Pr10) was
between two PstI-sites in the epr gene. Two auxiliary
plasmids, pCBT-epr and pCBT(epr::Cm
R), were obtained
for construction of this linear fragment. The latter plas-
mid served as a vector for the cloning of the mpr
B.amy
cassette from pHE52mpr, resulting in pCBT(epr-mpr52).
The linear epr::Cm
R DNA fragment and pCBT(epr-
mpr52) were used for integration of the second copy of
the mpr
B.amy cassette and construction of the JE852
(aprE851, epr)::mpr
B.amy strain.
The third integration was based on the linear DNA
fragment, nprB::Cm
R, carrying the nprB gene (the pri-
mers-Pr11/Pr12) disrupted by a HindIII-generated Cm
R-
carrier amplicon from pC194 (primers-Pr9/Pr10) that
was inserted into the unique HindIII site in the struc-
tural part of nprB. Construction of this fragment was
provided through formation of the auxiliary plasmid
pCBT(nprB::Cm
R). This plasmid was used later as a vec-
tor for cloning of the PstI-generated mpr
B.amy cassette
instead of Cm
R disrupted of nprB and construction of
pCBT(nprB-mpr52). It was possible so long as the Pr9/
Pr10 were designed for bracketing the Cm
R-marker by
(HindIII-PstI)/(PstI-HindIII) sites. The linear DNA frag-
ment, nprB::Cm
R,a n dt h ep C B T ( nprB-mpr52) plasmid
were used for construction of the JE852(aprE851, epr,
nprB)::mpr
B.amy strain that possessed three copies of the
mpr
B.amy-cassette in the targeted loci of the bacterial
chromosome.
Construction of DNA fragments for random integration of
the mpr
B.amy-cassette
At o t a lo f5μg of chromosomal DNA from B. subtilis
JE852 was exhaustively hydrolyzed by BamHI, followed
by self-circularization of the linear DNA fragments by
treatment with T4 ligase in 1 mL of reaction mixture.
This DNA was then digested by PstI and ligated with 5
μgo fPstI-generated mpr
B.amy-Cm
R-cassette from pHE52
(mpr-Cm
R) that had been purified from low melting
agarose. The ligation mixture was digested by BamHI,
and about 1 μg of the total DNA was used for the trans-
formation of B. subtilis JE852.
Segregation stability test
About 10
2 cells from overnight cultures of the B. subtilis
JE852-(Nxyz::mpr
B.amy-Cm
R) strains were inoculated into
10 mL of fresh LB medium, cultivated for 20 genera-
tions and cloned. One hundred individual colonies were
tested for Cm resistance. Strains that generated 100%
Cm
R clones after 20 generations were tested for stability
after 40 generations and then again after 60 generations.
Finally, JE852-(Nxyz::mpr
B.amy-Cm
R) strains, which gen-
erated 100 Cm
R colonies among the 100 that were
tested after 60 generations, were considered to be stable
and were used as donors of chromosomal DNA for
increasing the mpr
B.amy-cassette copy-number.
Protein analysis
SDS-PAGE was conducted using Laemmli’s method [61]
for the evaluation of GSP accumulation in the culture
supernatants of B. subtilis strains. Gels were stained
with Coomassie R-250 and scanned to estimate the pro-
tein content with the TotalLab v. 2.01 computer soft-
ware for determine the portion of GSP among the
secreted proteins. Total extracellular protein concentra-
tions were determined using the Bio-Rad Protein Assay
(Bio-Rad, USA) in accordance with the manufacturer’s
instructions. In addition, the known concentrations of
the commercially available carbonic anhydrase from
bovine erythrocytes (Sigma) with Mw 29 kDa were used
for SDS-PAGE followed by staining and scanning the
gel for comparative evaluation of GSP production. Both
independent methods gave, practically, coincident
results.
Additional material
Additional file 1: Table S1. List of primers used for PCR.
Additional file 2: Figure S1. Construction of the linear DNA fragment
used for the JE852aprE:: mpr
B.amystrain construction.
Additional file 3: Table S2. Bacterial strains and plasmids used.
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